3.75 ug Panblok H7: Clinical Trials

1 trial of 3.75 ug Panblok H7, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow 3.75 ug Panblok H7: new trials by email Literature Review of 3.75 ug Panblok H7 trials Research Report on 3.75 ug Panblok H7

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Panblok H7 Vaccine Adjuvanted With AS03 or MF59
3.75 ug Panblok H7, 7.5 ug Panblok H7, 15 ug Panblok H7 - Influenza, Human
Phase 2CompletedBiomedical Advanced Research and Development Authority3662017-09-202020-05-06

Conditions studied

Influenza in Birds (1)  ·  Influenza, Human (1)  ·  Orthomyxoviridae Infections (1)  ·  RNA Virus Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Virus Diseases (1)

Sponsors

Biomedical Advanced Research and Development Authority (1)

Countries

United States (1)

Top investigators

Carlos Fierro, MD (1)  ·  Mark Adams, MD (1)  ·  Matthew Davis, MD (1)  ·  Terry Poling, MD (1)